NOVELION THERAPEUTICS INC. License Agreements
2 Contracts & Agreements
- License Agreement, dated February 5, 2019, by and between Aegerion Pharmaceuticals, Inc. and Recordati Rare Diseases Inc (Filed With SEC on May 7, 2019)
- CONFIDENTIAL TREATMENT REQUESTED BY QLT INC. LICENSE AGREEMENT (Filed With SEC on September 3, 2008)
